Pseudophakic CME - Recurrent twice off topical therapy
|
|
74 year old man - The left eye had had blurred vision for one year. He has been on PF QID for about a month then after a week the vision cleared and he decreased his drops to once daily. He was on another drop which he doesn't remember. (may have been prolensa daily) Then when the patient went to see you for the follow-up the patient noticed the vision was blurred. His cataract surgery was 14 month ago. He is back up to QID drops in the left eye for about a week.
Medical Hx: Heart Disease. Hypertension, Systemic. Cartoid Artery Disease. Atrial Fibrillation. neuropathy (Knees down). Enlarged Prostate.
Surgical Hx: Knee Surgery (Left 2014). Heart Stent (2).
Systemic Meds: LOSARTAN. potassium. alfuzosin hydrochloride 10 MG 24 HR Extended Release Oral Tablet. atorvastatin (as atorvastatin calcium) 40 MG Oral Tablet. omeprazole 20 MG Delayed Release Capsule. COQ10. GLUCOSAMINE/CHONDROITIN. CENTRUM SILVER. MONTELUKAST. ZYRTEC. Zydenafil. DILTIAZEM. ISOSORBIDE MONONITRATE. Eliquis 5 MG Oral Tablet. GABAPENTIN. Testosterone Cypionate, cypionate 200 mg/mL intramuscular solution. CLOPIDOGREL. FINASTERIDE.
VA OD: sc20/20-1 NccJ1-1
VA OS: sc20/63 PH20/50-2 NccJ7
IOP: TP: OD:16 OS:18
The patient’s vision substantially declines with the CME. The patient treated initially with drops (PF and Ketorolac QID) and did OK but then had trouble with compliance. Had PST Kenalog but IOP went to 30. Then failed taper to QD PF Ketorolac twice. Now on BID PF, Ketorolac, and Dorz/Timolol (for steroid response) . Moved out of town.
Chronic CME controlled with BID PF, Ketorolac, and Dorz/timolol
|
Pseudophakic CME chronicvaatamisi: 13874 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol
(0 hinnangut)
|
|
Pseudophakic CME chronicvaatamisi: 11574 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol
(0 hinnangut)
|
|
Pseudophakic CME chronicvaatamisi: 15774 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol
(0 hinnangut)
|
|
Pseudophakic CME chronicvaatamisi: 14974 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol
(0 hinnangut)
|
|
Pseudophakic CME chronicvaatamisi: 12474 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol
(0 hinnangut)
|
|
Pseudophakic CME chronicvaatamisi: 11874 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol
(0 hinnangut)
|
|
Pseudophakic CME chronicvaatamisi: 13374 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol
(0 hinnangut)
|
|
Pseudophakic CME chronicvaatamisi: 13774 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol
(0 hinnangut)
|
|
Pseudophakic CME chronicvaatamisi: 14774 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol
(0 hinnangut)
|
|
Pseudophakic CME chronicvaatamisi: 12974 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol
(0 hinnangut)
|
|
Pseudophakic CME chronicvaatamisi: 15374 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol
(0 hinnangut)
|
|
Pseudophakic CME chronicvaatamisi: 13574 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol
(0 hinnangut)
|
|
Pseudophakic CME chronicvaatamisi: 14174 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol
(0 hinnangut)
|
|
Pseudophakic CME chronicvaatamisi: 13574 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol
(0 hinnangut)
|
|
Pseudophakic CME chronicvaatamisi: 14474 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol
(0 hinnangut)
|
|
Pseudophakic CME chronicvaatamisi: 14674 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol
(0 hinnangut)
|
|
Pseudophakic CME chronicvaatamisi: 14474 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol
(0 hinnangut)
|
|
Pseudophakic CME chronicvaatamisi: 13074 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol
(0 hinnangut)
|
|
Pseudophakic CME chronicvaatamisi: 14874 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol
(0 hinnangut)
|
|
Pseudophakic CME chronicvaatamisi: 12774 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol
(0 hinnangut)
|
|
Pseudophakic CME chronicvaatamisi: 11874 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol
(0 hinnangut)
|
|
Pseudophakic CME chronicvaatamisi: 10774 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol
(0 hinnangut)
|
|
|
|
|
|
74 year old man - The left eye had had blurred vision for one year. He has been on PF QID for about a month then after a week the vision cleared and he decreased his drops to once daily. He was on another drop which he doesn't remember. (may have been prolensa daily) Then when the patient went to see you for the follow-up the patient noticed the vision was blurred. His cataract surgery was 14 month ago. He is back up to QID drops in the left eye for about a week.
Medical Hx: Heart Disease. Hypertension, Systemic. Cartoid Artery Disease. Atrial Fibrillation. neuropathy (Knees down). Enlarged Prostate.
Surgical Hx: Knee Surgery (Left 2014). Heart Stent (2).
Systemic Meds: LOSARTAN. potassium. alfuzosin hydrochloride 10 MG 24 HR Extended Release Oral Tablet. atorvastatin (as atorvastatin calcium) 40 MG Oral Tablet. omeprazole 20 MG Delayed Release Capsule. COQ10. GLUCOSAMINE/CHONDROITIN. CENTRUM SILVER. MONTELUKAST. ZYRTEC. Zydenafil. DILTIAZEM. ISOSORBIDE MONONITRATE. Eliquis 5 MG Oral Tablet. GABAPENTIN. Testosterone Cypionate, cypionate 200 mg/mL intramuscular solution. CLOPIDOGREL. FINASTERIDE.
VA OD: sc20/20-1 NccJ1-1
VA OS: sc20/63 PH20/50-2 NccJ7
IOP: TP: OD:16 OS:18
The patient’s vision substantially declines with the CME. The patient treated initially with drops (PF and Ketorolac QID) and did OK but then had trouble with compliance. Had PST Kenalog but IOP went to 30. Then failed taper to QD PF Ketorolac twice. Now on BID PF, Ketorolac, and Dorz/Timolol (for steroid response) . Moved out of town.
Chronic CME controlled with BID PF, Ketorolac, and Dorz/timolol
